ICUNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as ICUCW
SeaStar Medical Holding Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$3.11+0.21 (+7.24%)
Close on Oct 19, 2026
- Market cap
- $12.70M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$3.02 (−49.29%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
SeaStar Medical Holding Corp grew revenue 123.6% to $1.71M over the twelve months to Jun 30, 2026.
Revenue
$1.71M
+123.6% vs. a year earlier
Operating income
-$13.99M
TTM Q2 2026
EPS, diluted
-$3.93
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $12.70M
- P/E ratio
- –
- Price to sales
- 7.42
- Price to book
- 2.96
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $1.71M
- Net income
- -$13.63M
- EPS, diluted
- -$3.93
- Book value per share
- $1.05
- Diluted shares
- 4M
Six years at a glance
Fiscal years 2020 to 2025 and trailing twelve months, USD
Revenue
$1.71M+123.6% YoY
Gross profit
$1.59M+114.7% YoY
Operating income
-$13.99M
Net income
-$13.63M
EPS, diluted
-$3.93
Reported periodTrailing twelve months